Clinical staging of HIV-related illness in mozambique: Performance of nonphysician clinicians based on direct observation of clinical care and implications for health worker training

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 3, 2010, Pages 351-355

  Brentlinger, Paula E ^a   Torres, José Vallejo ^b   Martínez, Pilar Martínez ^b   Ghee, Annette ^a   Lujan, Johnny ^c   Bastos, Rui ^d   Manuel, Rolanda ^d   Mudender, Florindo M ^d   Assan, Américo ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b International Training and Education Center on HIV   (Mozambique)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d MINISTRY OF HEALTH   (Mozambique)

Author keywords

HIV AIDS; Mozambique; staging; training

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DIAGNOSTIC ERROR; DIARRHEA; FEVER; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MOZAMBIQUE; PATIENT CARE; PRIORITY JOURNAL; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION; ADULT; HEALTH SERVICES RESEARCH; HIV INFECTIONS; NURSE; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

ADULT; ANTI-HIV AGENTS; EDUCATION, MEDICAL; HEALTH SERVICES RESEARCH; HIV INFECTIONS; HUMANS; MOZAMBIQUE; NURSES; SEVERITY OF ILLNESS INDEX;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EID: 78049244848     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181e3a4cd     Document Type: Article

References (20)

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services, December 1, 2009. Available at: http://www.aidsinfo.nih.gov/ContentFiles/Adultand AdolescentGL.pdf. Accessed December 2, 2009.
2. Wate P, Insel M, Calu M, et al. Effective ways to establish and use a quality improvement system to improve programs in treatment and care settings in Mozambique [MOPE0890]. Presented at XVII International AIDS Conference, 2008, Mexico City, Mexico.
3. Republic of Mozambique. National AIDS Council. Universal Declaration of Commitment on HIV/AIDS. Progress report for United Nations General Assembly special session on HIV/AIDS. January 2008.
4. Sam B, Celletti F, Holloway J, et al. Rapid expansion of the health workforce in response to the HIV epidemic. N Engl J Med. 2007;357: 2510-2514.
5. Sherr K, Pfeiffer J, Mussa A, et al. The role of nonphysician clinicians in the rapid expansion of HIV care in Mozambique. J Acquir Immune Defic Syndr. 2009;52:S20-S23.
6. Assan A, Mudender F, Brentlinger PE, et al. A method for evaluation of quality of HIV/AIDS care after in-service training in antiretroviral therapy for Mozambican mid-level providers [WePE1070]. Presented at XVII International AIDS Conference, 2008, Mexico City, Mexico.
7. World Health Organization. Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach. 2003 Revision. Geneva, Switzerland: World Health Organization; 2004.
8. World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. Geneva, Switzerland: World Health Organization 2006.
9. República de Moxcambique. Ministério da Saúde. Direcxcão Nacional de Saúde. Programa Nacional de Controle das ITS/HIV/SIDA. Curso Básico de HIV/SIDA e Infecxcões Oportunistas. Maputo, Mozambique: Ministério da Saúde; 2005.
10. República de Moxcambique. Ministério da Saúde. Direcxcão Nacional de Saúde. Programa Nacional de Controle das ITS/HIV/SIDA. Tratamento
11. AntiRetroViral para Técnicos de Medicina. Maputo, Mozambique: Ministério da Saúde 2006.
12. Kagaayi J, Makumbi F, Nakigozi G, et al. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda. AIDS. 2007;21:1208-1210.
13. 3 in an HIV type 1-infected African population. AIDS Res Hum Retroviruses. 2007;23:1230-1236.
14. McGrath N, Kranzer K, Saul J, et al. Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi. AIDS. 2007;21(Suppl 6):S105-S113.
15. Lynen L, Thai S, de Munter P, et al. The added value of a CD4 count to identify patients eligible for highly active antiretroviral therapy among HIV-positive adults in Cambodia. J Acquir Immune Defic Syndr. 2006;42: 322-324.
16. Van der Paal L, Shafer LA, Todd J, et al. HIV-1 disease progression and mortality before the introduction of highly active antiretroviral therapy in rural Uganda. AIDS. 2007;21(Suppl 6):S21-S29.
17. Ngoma D, Makombe SD, Kamoto K, et al. World Health Organization clinical stage 3 disease conditions in HIV-infected patients who start antiretroviral therapy in Malawi. Trop Doct. 2008;38:159-160.
18. Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/ AIDS. AIDS. 2009;23:525-530.
19. Liechty CA, Solberg P, Were W, et al. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health. 2007;12:1-7.
20. Philips M, Zachariah R, Venis S. Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea. Lancet. 2008;371: 682-684.